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lthough caveolins normally reside in caveolae,
they can accumulate on the surface of cytoplasmic
lipid droplets (LDs). Here, we ﬁrst provided support
for our model that overaccumulation of caveolins in the
endoplasmic reticulum (ER) diverts the proteins to nascent
LDs budding from the ER. Next, we found that a mutant
H-Ras, present on the cytoplasmic surface of the ER but
lacking a hydrophobic peptide domain, did not accumu-
late on LDs. We used the fact that wild-type caveolin-1
A
 
accumulates in LDs after brefeldin A treatment or when
 
linked to an ER retrieval motif to search for mutants defec-
 
tive in LD targeting. The hydrophobic domain, but no
 
speciﬁc sequence therein, was required for LD targeting of
caveolin-1. Certain Leu insertions blocked LD targeting,
 
independently of hydrophobic domain length, but dependent
on their position in the domain. We propose that proper
packing of putative hydrophobic helices may be required
for LD targeting of caveolin-1.
 
Introduction
 
Lipid droplets (LDs), which are present in the cytoplasm of
most eukaryotic cells, consist of triacylglyceride and steryl
ester–rich cores surrounded by phospholipid monolayers
(Londos et al., 1999; Zweytick et al., 2000; Murphy, 2001).
LDs are thought to form by budding from the ER through
 
an unusual and poorly characterized mechanism. First,
neutral lipids (synthesized in the ER membrane) accumulate
in the center of the bilayer and form disks. Next, the disks
bulge into the cytoplasm as they enlarge and eventually bud
from the ER as LDs, acquiring ER-derived phospholipid
monolayers in the process.
Although no proteins are known to reside in the hydro-
 
phobic LD core, several proteins are targeted to the LD
surface. Little is known about the function of most of these.
Among the best understood are the oleosins, which are
abundant proteins in certain plants seeds that prevent oil
body (plant LD) coalescence during desiccation (Huang,
1992; Murphy, 2001). Oleosins are targeted to oil bodies
when expressed in animal cells, showing that targeting
mechanisms are conserved between kingdoms (Hope et al.,
 
2002). Caleosins, which are related to oleosins, are Ca
 
2
 
 
 
-
binding LD proteins of unknown function in plants and
fungi (Chen et al., 1999; Naested et al., 2000). The best
characterized LD proteins in animal cells are the perilipins,
which coat the LD surface in adipocytes and steroidogenic
cells. Londos et al. (1999) have shown that the phosphoryla-
 
tion state of perilipins regulates the access of hormone-sensitive
lipase to the LD surface, and that this regulates mobilization
of lipid stores (Tansey et al., 2003). Consistent with this
 
model, regulation of lipid metabolism in adipocytes is
perturbed in perilipin-deficient mice (Martinez-Botas et al.,
2000; Tansey et al., 2001). A related LD protein, adipocyte
differentiation related protein (ADRP) or adipophilin, is
widely distributed in mammalian cells (Brasaemle et al.,
1997b). The core proteins of hepatitis C virus (HCV) and
the related GB virus-B (GBV-B) are also targeted at least
partially to LDs (Barba et al., 1997; Hope et al., 2002). Other
proteins, such as hormone-sensitive lipase in adipocytes, can
associate with LDs transiently (Egan et al., 1992).
LD proteins fall into two structural classes. The first class
includes perilipins and ADRP. Perilipins have no long hydro-
 
phobic domains, are made on free polysomes (Brasaemle et al.,
1997a), and are probably targeted directly from the cytosol
to the LD surface. It has not been possible to identify simple
discrete LD targeting motifs in either perilipins or ADRP
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(Garcia et al., 2003; McManaman et al., 2003; Nakamura
and Fujimoto, 2003; Targett-Adams et al., 2003). Rather,
LD targeting of both perilipin A (Garcia et al., 2003) and
ADRP (Targett-Adams et al., 2003) involves redundant, dis-
continuous sequences.
The second class of LD proteins, which includes oleosins
and caleosins, are “integral” LD proteins. These proteins share
a distinctive topology. Hydrophilic NH
 
2
 
- and COOH-termi-
nal cytoplasmic domains flank a central hydrophobic domain,
which can range in length from 
 
 
 
30 to 
 
 
 
70 residues (in the
case of oleosins), and is presumed to be embedded in the hy-
drophobic LD core. The structure of the hydrophobic do-
main of oleosins is controversial. It may assume a 
 
 
 
 strand
conformation, interacting with adjacent strands to form a par-
allel 
 
 
 
 sheet (Li et al., 1992, 2002), or may contain a central
tight turn between two antiparallel 
 
 
 
 strands (Huang, 1992;
Tzen et al., 1992), or may be 
 
 
 
-helical (Lacey et al., 1998).
HCV and GBV-B core proteins have also been included in
the class of integral LD proteins (Hope et al., 2002). The cen-
tral domains of these proteins are fairly hydrophobic, al-
though they contain several charged residues.
Correct targeting of oleosins is known to depend on signal
recognition particle and the Sec61 translocon (Beaudoin et
al., 2000; Abell et al., 2002). Thus, integral LD proteins are
probably cotranslationally inserted in the ER membrane and
diffuse in the ER bilayer to access the surface of nascent LDs
while these are still embedded in the ER membrane. Access
to the LD surface is only possible because these proteins lack
hydrophilic domains on the luminal side of the membrane,
as such domains could not be accommodated in the hydro-
phobic LD core. As expected, no transmembrane LD pro-
teins are known. Integral LD proteins are highly concen-
trated on the LD surface, presumably reflecting a high
affinity for the LD surface relative to the ER.
The central hydrophobic domain is required for LD tar-
geting of oleosins and HCV core (Hope and McLauchlan,
2000; Hope et al., 2002). In addition, a “Pro knot” motif,
consisting of three closely-spaced Pro residues at the center
of the long hydrophobic domain, is present in oleosins
(Tzen et al., 1992) and is required for their LD targeting
(Abell et al., 1997). A similar motif is present in caleosins
(Naested et al., 2000). Two closely spaced Pro residues near
the hydrophobic domains of HCV and GBV-B core pro-
teins appear to play a similar role, as they are required for
LD targeting of HCV core (Hope et al., 2002).
Caveolin proteins are components of cell-surface caveolae
(Smart et al., 1999). Caveolins-1 and -2 are widely distrib-
uted among mammalian cell types and are normally coex-
pressed, whereas caveolin-3 is muscle specific. Caveolin-2
accumulates in the Golgi apparatus (Mora et al., 1999; Paro-
lini et al., 1999) and in LDs (Fujimoto et al., 2001; Oster-
meyer et al., 2001) unless caveolin-1, with which it hetero-
oligomerizes, is coexpressed.
Caveolins can sometimes accumulate in LDs, where they
may function in signaling and cholesterol balance (Fujimoto
et al., 2001; Ostermeyer et al., 2001; Pol et al., 2001). Cave-
olins were found in LDs under the following four conditions:
(1) when sequences in the NH
 
2
 
-terminal hydrophilic domain
were deleted, (2) when an ER-retrieval signal was linked to
caveolin-1, (3) when caveolin-2 was expressed without caveo-
lin-1, and (4) when cells were treated with brefeldin A (BFA)
to block transport from the ER to the Golgi apparatus. We
proposed the following model to unify these observations
(Ostermeyer et al., 2001). Because caveolins have the same
topology as the aforementioned integral LD proteins, we
proposed that caveolins have a high affinity for LDs. We sug-
gested that after synthesis, the proteins are usually rapidly
packaged into transport vesicles, preventing them from
reaching the surface of nascent LDs. The vesicle packaging
mechanism can be saturated though, and certain caveolin
mutants are not recognized. These conditions lead to accu-
mulation of caveolins in the ER, and then to LD targeting via
the same mechanism used by other integral LD proteins.
Caveolin-2 was initially proposed to have a higher affinity
for LDs than the other caveolins (Fujimoto et al., 2001).
However, caveolin-1 is also highly concentrated in LDs
Figure 1. Effect of drugs on LD accumulation of caveolin-1. COS 
cells were left untreated (A–C) or treated with BFA alone (D–F) or 
BFA with nocodazole (G–I), cytochalasin B (J–L), or cycloheximide 
(M–O) for 5 h. Caveolin-1 was detected by IF with anti–caveolin-1 
and Alexa Fluor 350-GAR (left) and LDs with Nile red (center). Right, 
merged images. Images were taken with a 100  objective. Each 
image shows a portion of one cell; for orientation, dark areas at 
lower right in F and I are the edges of nuclei. Bar, 5  m. 
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when linked to an ER retrieval signal (Ostermeyer et al.,
2001). Caveolin-2 is transported inefficiently through the
secretory pathway in the absence of caveolin-1 (Mora et al.,
1999; Parolini et al., 1999). Thus, LD accumulation of ca-
veolin-2 may result from inefficient transport out of the ER.
Here, we first provide further evidence that accumulation
of caveolin-1 in the ER leads to LD targeting. To determine
whether any protein on the cytosolic face of the ER that
lacked transmembrane domains could concentrate in LDs,
we examined H-Ras, which is initially targeted to the cyto-
solic face of the ER. Finally, a major goal of this work was to
use caveolin-1 as model to define LD targeting signals.
 
Results
 
Caveolin-1 is normally concentrated in caveolae, and not in
LDs, in COS cells (Fig. 1, A–C), but accumulates in LDs af-
ter 5 h of BFA treatment (Ostermeyer et al., 2001; Fig. 1, D–F).
LDs were identified with the lipophilic dye Nile red (Fig. 1,
B and E). Although not clear in Fig. 1, caveolin-1 also re-
mained abundant in caveolae after BFA treatment. Here, we
used the ability of BFA to induce LD accumulation of caveo-
lin-1 to identify factors that blocked that targeting.
 
BFA-induced LD accumulation of caveolin-1 
requires ongoing protein synthesis but not 
microtubules or microfilaments
 
To determine whether BFA-induced LD accumulation re-
quired an intact cytoskeleton, COS cells in which microtu-
bules were disrupted with nocodazole, or microfilaments dis-
rupted with cytochalasin B, were treated with BFA for 5 h.
Neither drug inhibited BFA-induced LD accumulation (Fig.
1, G–L; although not depicted, LDs sometimes appeared
clumped after nocodazole treatment). However, blocking pro-
tein synthesis with cycloheximide greatly reduced BFA-induced
LD accumulation, and the protein was mostly seen in punc-
tate caveolae (Fig. 1, M–O). Cycloheximide treatment did
not affect LD density or size. These findings are consistent
with our proposal that newly synthesized caveolin-1 enters na-
scent LDs by diffusion in the ER membrane and cannot enter
LDs after leaving the ER (Ostermeyer et al., 2001).
Further experiments examining transfected proteins were
performed either in COS or Fischer rat thyroid (FRT) cells,
 
which lack endogenous caveolin-1 and caveolae, but can as-
semble exogenously expressed caveolin-1 into caveolae
(Lipardi et al., 1998). The localization of caveolin-1 in
transfected FRT cells is very similar to that in COS cells
(Lipardi et al., 1998; Ostermeyer et al., 2001). In both cell
types, we saw caveolin-1 in the Golgi apparatus as well as in
caveolae, as reported previously (Dupree et al., 1993; Den-
ker et al., 1996; Luetterforst et al., 1999).
 
H-Ras does not concentrate in LDs
 
To see if any overexpressed protein on the cytoplasmic surface
of the ER entered LDs nonspecifically, we examined H-Ras,
which is recruited to the ER after synthesis and reaches the
plasma membrane via the secretory pathway (Choy et al.,
1999). Ras proteins move slowly through the secretory path-
way and are seen in the ER and Golgi apparatus at steady state.
We saw no LD staining of EGFP–H-Ras expressed in COS
cells (unpublished data). Because plasma membrane staining
might have obscured LD staining, we expressed an EGFP mu-
tant nonpalmitoylated H-Ras, which remains in the ER and
Golgi apparatus and does not reach the cell surface (Choy et
al., 1999). To identify LDs, we coexpressed Cav-KKSL (caveo-
lin-1 with an appended ER retrieval motif), which accumulates
in LDs even without BFA (Ostermeyer et al., 2001). Non-
palmitoylated H-Ras had a diffuse ER localization (Fig. 2, A
and B) and was detected only rarely (
 
 
 
5% of transfected cells)
in Cav-KKSL–positive LDs with or without BFA treatment.
 
A transmembrane protein is excluded from LDs after 
BFA treatment
 
To confirm that transmembrane proteins were excluded
from LDs, we cotransfected FRT cells with Cav-KKSL and
the hybrid protein placental AP (PLAP)–HA (Arreaza and
Brown, 1995), treated them with BFA for 5 h, and pro-
cessed them for indirect immunofluorescence microscopy
 
(
 
IF). As expected, PLAP-HA was never detected in LDs in
FRT cells (Fig. 2 C) or in COS cells (not depicted).
 
BFA-induced LD targeting of caveolin mutants
 
In the rest of this work, we examined caveolin-1 mutants, at-
tempting to identify sequences needed for LD targeting. We
first examined mutants in BFA-treated FRT cells, searching
for those that failed to accumulate in LDs. Mutants are sche-
Figure 2. Neither H-Ras nor the transmem-
brane protein PLAP-HA accumulate in LDs. 
(A, B, D, and E) GFP-tagged nonpalmitoylated 
H-Ras (A and B) and Cav-KKSL (D and E) were 
coexpressed in COS cells. Cells were not treated 
(A and D; same cell) or treated (B and E; same 
cell) with BFA for 5 h. Mutant H-Ras was visual-
ized by GFP fluorescence, and caveolin-KKSL 
by IF, using Texas red–GAR. (C and F) In one 
cotransfected, BFA-treated FRT cell, PLAP-HA 
was detected with anti-PLAP and FITC-GAR (C), 
and Cav-KKSL was detected with anti-myc and 
Texas red–GAM (F). 
72 The Journal of Cell Biology 
 
|
 
 
 
Volume 164, Number 1, 2004
 
matically diagrammed and the results are listed in Fig. 3, with
pictures of selected mutants shown in Figs. 4 and 5. After BFA
treatment, in FRT cells, as in COS cells, wild-type caveolin-1
was present in structures with the characteristic round shape of
LDs (Fig. 4 A, arrows) that stained for the LD marker protein
ADRP (Fig. 5, A–C) in 66 
 
 
 
 15% (
 
n 
 
  
 
6) of transfected cells
after BFA treatment. Although the methanol fixation required
for efficient detection of ADRP distorted LD shape, as re-
ported previously (DiDonato and Brasaemle, 2003), colocal-
ization of ADRP and caveolin was clear (Fig. 5, A–C). Caveo-
lin-1 staining was also seen in caveolae, which did not stain for
ADRP. Without BFA treatment, wild-type caveolin-1 was oc-
casionally (
 
 
 
5% of cells) seen in LDs in FRT cells, in the very
highest expressing cells (unpublished data). After BFA treat-
ment, caveolin-1 and all the mutants examined were also seen
in punctate structures larger than caveolae and distributed
throughout the cell (Fig. 4 A, arrowheads). These structures
 
did not stain for ADRP and were thus not related to LDs, but
stained for GM130 (unpublished data), and are probably ER
exit sites (Ward et al., 2001). The unusual behavior of caveo-
lin-1 in concentrating in these structures in BFA-treated cells
will be described elsewhere (unpublished data).
 
NH
 
2
 
-terminal domain mutants
 
 
 
N2, which lacks the downstream half of the NH
 
2
 
-terminal
domain (
 
 
 
46-95) of caveolin-1, accumulated in LDs with
(Fig. 3) or without (Ostermeyer et al., 2001) BFA treatment.
 
 
 
N2 lacks a domain required for oligomerization of caveolin-1
(Sargiacomo et al., 1995) and migrated as a monomer on ve-
locity gradients (unpublished data). Thus, oligomerization was
not required for LD targeting of caveolin-1. A quadruple sub-
stitution mutant near the end of the NH
 
2
 
-terminal domain,
97/SASA, showed efficient BFA-induced LD localization, as
did 
 
 
 
N1 (
 
 
 
3-48), which lacked most of the first half of
the NH
 
2
 
-terminal domain (Fig. 3). Because these mutants
spanned the NH
 
2
 
-terminal domain (except for S2, K96, and
R101), no sequences in this domain were required for LD tar-
geting. BFA-induced LD targeting of 97/SASA, chosen as a
representative mutant, was verified by colocalization with
ADRP (Fig. 5, D–F). BFA significantly reduced overall ADRP
staining in FRT cells. However, expression of wild-type or mu-
Figure 3. BFA-induced LD accumulation of wild-type and mutant 
caveolin-1. FRT cells expressing the indicated proteins were treated 
with BFA for 5 h, and caveolin-1 was detected by IF. Proteins are 
listed by name and diagrammed schematically (not to scale). The 
NH2-terminal, hydrophobic, and COOH-terminal domains of 
caveolin-1 are schematized as open, shaded, and open boxes, 
respectively. Deletions are schematized as gaps, substitutions as 
closed triangles, and 7-Leu insertions as open triangles. Except for 
the hydrophobic domain mutants (102A5–130A5), the number of 
triangles corresponds to the number of changes. Mutants in the 
hydrophobic domain (Hyd D), NH2-terminal domain (NTD), and 
COOH-terminal domain (CTD) are grouped together. Pic., IF images 
of these proteins are shown in the indicated panels of Fig. 4.
Figure 4. Localization of wild-type and mutant caveolin-1 in BFA-
treated FRT cells. (A) Caveolin-1; (B)  101-134; (C) 118A5; (D) 123A6; 
(E)  112-125; (F)  59; (G) Ins7L(1 2); (H) Ins-7L1; (I) Ins-7L2; (J) 
Ins-14L; (K) Ins7L(1 2)   112-125; and (L)  C. Cells were treated 
with BFA for 5 h. Proteins were visualized by IF, using anticaveolin 
antibodies and DTAF-GAR. Arrows, LDs. Arrowheads, puncta staining 
for GM130 (not depicted), presumed to be ER exit sites. 
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tant caveolin-1 did not induce LD formation or alter LD den-
sity, as shown by comparison of ADRP staining in transfected
and untransfected cells (Fig. 5; each panel shows two cells, only
one of which was transfected). 97/SASA was not transported to
the cell surface as efficiently as wild-type caveolin-1, explaining
why this mutant was less prominent in ADRP-negative caveo-
lae than was the wild-type protein (Fig. 5, compare C with F).
 
Hydrophobic domain mutants
 
As both the last 20 residues of the NH
 
2
 
-terminal domain
(Schlegel et al., 1999; Arbuzova et al., 2000) and the COOH-
terminal domain (Luetterforst et al., 1999; Schlegel and
Lisanti, 2000) of caveolin-1 can associate with membranes in-
dependently, the hydrophobic domain is not required for
membrane association. A caveolin-1 mutant lacking the hydro-
phobic domain (
 
 
 
101-134) was detected in the Golgi appara-
tus and the plasma membrane by IF (unpublished data). How-
ever, this mutant was not seen in LDs after BFA treatment.
Similar behavior was reported for an equivalent caveolin-2 mu-
tant (Fujimoto et al., 2001). Instead, it was concentrated in
 
punctate GM130-positive structures (Fig. 4 B). To determine
the importance of specific hydrophobic domain residues in LD
targeting, we examined a series of mutants in which sequential
groups of five or six residues, through the hydrophobic do-
main, were changed to Ala. The mutants, named for the posi-
tion of the first substitution and the number of substitutions,
are diagrammed in Fig. 3, starting with 102A5. All of these
mutants accumulated in LDs as efficiently as wild-type caveo-
lin-1 after BFA treatment, as shown for 118A5 (Fig. 4 C) and
123A6 (Fig. 4 D). We conclude that no individual residues in
the hydrophobic domain were required for LD targeting.
The next two caveolin-1 mutants suggested that the topol-
ogy of the hydrophobic domain, rather than its length,
might be important in LD targeting. We first deleted the
central 14 residues from the hydrophobic domain, generat-
ing 
 
 
 
112-125. Upon BFA treatment, this mutant was seen
in LDs (Fig. 4 E). However, the mutant 
 
 
 
59, which lacked
the last 59 residues of the protein and ended in the middle
of the hydrophobic domain (with no myc tag), did not con-
centrate in LDs after BFA treatment (Fig. 4 F). These differ-
ences were observed although the hydrophobic domains of
 
 
 
112-125 and 
 
 
 
59 were very similar in length (18 residues
in 
 
 
 
59, 19 residues in 
 
 
 
112-125).
 
Some insertion mutants are excluded from LDs
 
Next, we examined the effect of lengthening the hydrophobic
domain of caveolin-1 on LD targeting. Although we do not
know the conformation of the hydrophobic domain, we spec-
ulated that it might form two 
 
 
 
 helices, separated by a tight
turn. This possibility guided us in making insertion mutants.
With the aim of minimizing disruption of protein structure,
we first inserted two groups of seven Leu (each group pre-
dicted to form two helix turns, if the structure were helical)
into the hydrophobic domain, one near each end. The posi-
tions of the insertions were chosen to allow one helix turn of
native sequence in the membrane before the insertion. The re-
sulting protein, Ins-7L(1
 
 
 
2), was concentrated in the Golgi
apparatus and could be detected on the plasma membrane in
many untreated cells (unpublished data), suggesting that it
was not grossly misfolded. However, Ins-7L(1
 
 
 
2) was not de-
tected in LDs after BFA treatment (Fig. 4 G), but was instead
concentrated in the ER (not depicted) and in GM130-positive
puncta. Double labeling for caveolin-1 and ADRP confirmed
LD exclusion of Ins-7L(1
 
 
 
2), and comparison of ADRP
staining in transfected and untransfected cells showed that this
mutant did not affect LD size or density (Fig. 5, G–I).
Next, we made several new mutants to determine why this
double insertion mutant, Ins-7L(1
 
 
 
2), was excluded from
LDs. Ins7L-1 and Ins7L-2 each contained only one of the
two 7-Leu insertions present in Ins-7L(1
 
 
 
2). Both inser-
tions accumulated in LDs after BFA treatment (Fig. 4, H
and I). For unknown reasons, Ins-7L-2 accumulated in LDs
as well as the Golgi apparatus, even without BFA treatment.
Thus, exclusion of the double insertion mutant Ins-
7L(1
 
 
 
2) from LDs did not result from disruption of an LD
targeting signal by either insertion. Instead, it was possible
that simply increasing the length of the hydrophobic span by
14 residues prevented LD targeting. To test this idea, we
made two new double insertion mutants. A second group of
7 Leu was inserted in the hydrophobic domain of Ins-7L-1
Figure 5. Localization of wild-type and mutant caveolin-1 and 
ADRP in BFA-treated FRT cells. FRT cells expressing caveolin-1 
(A–C), 97/SASA (D–F), or Ins-7L(1 2) (G–I) were BFA treated for 4 h 
and methanol fixed. Caveolin and mutants were detected by IF, 
using (A and G) Texas red–GAR or (D) FITC-GAR. ADRP was 
detected in the transfected cells and neighboring untransfected cells 
using (B and H) DTAF-GAM or (E) Texas red–GAM. (C, F, and I) 
Merged images. (A and B) Yellow arrows indicate some regions 
of overlap. 
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close to the site of the first insertion, generating Ins-14L,
which thus contained 14 Leu inserted near the NH
 
2
 
-terminal
end of the hydrophobic domain. BFA-induced LD accumu-
lation of Ins-14L was similar to wild type (Fig. 4 J), suggest-
ing that exclusion of Ins-7L(1
 
 
 
2) (the original double inser-
tion mutant) from LDs did not result simply from the
increased length of its hydrophobic domain. Another mu-
tant, (Ins-7L(1
 
 
 
2)/
 
 
 
112-125), supported this conclusion.
To make the mutant, we deleted the central 14 residues from
the hydrophobic domain of Ins-7L(1
 
 
 
2). Thus, this mutant
contained both of the original 7-Leu insertions, but its hy-
drophobic span was the same length as that of wild-type ca-
veolin-1. Like Ins-7L(1
 
 
 
2), this mutant was virtually never
detected in LDs after BFA treatment (Fig. 4 K). This finding
suggested that the failure of Ins-7L(1
 
 
 
2) to target to LDs
did not result from its increased hydrophobic span length.
To explain these results, we speculated that the bulky Leu
side chains on the inserted residues in Ins-7L(1
 
 
 
2) blocked
LD targeting through a steric effect by preventing proper
packing of the residues in the hydrophobic domain with
each other or with other proteins in the bilayer. According
to this model, such an effect of either insertion alone could
be tolerated, but both together would be prohibitive.
 
Expression level of hydrophobic domain mutants does 
not correlate with LD localization
 
To ensure that apparent exclusion of certain mutants from
LDs did not result from low expression, we compared the
expression levels of selected mutants (Fig. 6). Mutants were
coexpressed with PLAP-HA as a transfection and loading
control. Expression levels of different mutants varied widely.
Although expression of Ins-7L(1
 
 
 
2) was quite low, two
other mutants that failed to accumulate in LDs, 
 
 
 
59 and
Ins-7L(1
 
 
 
2)
 
  
 
112-125, were expressed well (Fig. 6, lanes
1–6). Thus, expression levels of the hydrophobic domain
mutants did not correlate with LD accumulation.
Figure 6. Expression level of caveolin-1 mutants does not correlate 
with LD targeting. FRT cells were cotransfected with PLAP-HA (as a 
transfection and loading control) and either Ins-7L1 (lane 1), Ins-7L2 
(lane 2), Ins-7L(1 2)  112-125 (lane 3),  59 (lane 4), Ins-7L(1 2) 
(lane 5), or  112-125 (lane 6); or, in a separate experiment, analyzed 
on a separate gel with Ins-7L(1 2) (lane 7) or  C (lane 8). Cells 
were lysed with gel loading buffer and proteins in equal aliquots of 
lysate were analyzed by SDS-PAGE and Western blotting. Blots were 
cut, and the tops were probed with anti-PLAP antibodies and the 
bottoms with anticaveolin antibodies. Both halves were probed with 
HRP–donkey anti–rabbit IgG, and proteins were visualized by ECL.
Figure 7. Localization of KKSL-tagged caveolin-1 
mutants. FRT cells expressing Ins-7L1-KKSL (A–C), 
97/SASA-KKSL (D–F), Ins-7L(1 2)-KKSL (G–I), or Ins-
7L(1 2)  112-125-KKSL (J–L) were methanol fixed. 
Caveolin-1 proteins (A, D, G, and J) and ADRP in the 
same cells (B, E, H, and K) were detected by IF. (C, F, I, 
and L) Merged images. Schematic depictions of proteins 
are as in Fig. 3, except that only two triangles indicate 
the four substitutions in 97/SASA. *, KKSL tag. 
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The COOH-terminal domain may contribute to
LD targeting
Cys , a nonpalmitoylated triple Cys-Ser caveolin-1 mutant
(Dietzen et al., 1995), accumulated in LDs as well as the
wild-type protein (Fig. 3), showing that palmitoylation was
not required for LD targeting. A mutant lacking the entire
COOH-terminal domain,  C, was localized to the plasma
membrane and Golgi apparatus in untreated cells (unpub-
lished data), unlike a similar caveolin-2 mutant, which was
concentrated in the ER (Fujimoto et al., 2001). In BFA-
treated cells,  C was detected in LDs in fewer cells (30   7%
of transfected cells, n   5) than wild-type caveolin-1, and LD
staining, relative to staining of GM130-positive puncta, was
dimmer. Staining of the ER, including the nuclear envelope,
was more prominent, suggesting a reduced affinity for LDs
(Fig. 4 L). However,  C was expressed very poorly, at a level
similar to or less than Ins-7L(1 2) (Fig. 6, lanes 7 and 8).
Thus, the apparent partial reduction in LD targeting effi-
ciency may have resulted from decreased expression.
LD targeting of KKSL-tagged mutants
To ensure that our results did not depend on BFA treat-
ment, we appended KKSL ER retrieval tags to selected cave-
olin-1 mutants. Wild-type Cav-KKSL accumulates in LDs
even without BFA (Ostermeyer et al., 2001). Similarly,
KKSL-tagged forms of 97/SASA and Ins-7L1 were detected
in LDs in virtually every expressing cell (Fig. 7). This con-
trasted with the localization of the non-KKSL tagged ver-
sions of the same proteins in BFA-treated cells, in which LD
localization was detected in 60–80% of the cells. Increased
LD accumulation of the KKSL-tagged proteins probably re-
sulted from the fact that they were continuously retrieved to
the ER, instead of accumulating there for only 5 h during
BFA treatment. Nevertheless, KKSL-tagged forms of Ins-
7L(1 2) and Ins-7L(1 2)  112-125 were never seen in
LDs (Fig. 7), although Ins-7L(1 2)-KKSL was expressed
about as well as wild-type Cav-KKSL, 97/SASA-KKSL,
and Ins-7L1-KKSL. Ins-7L(1 2)  112-125-KKSL was
expressed at a higher level (unpublished data). Thus, the in-
ability of certain mutants to accumulate in LDs did not de-
pend on BFA treatment.
Caveolin-1 mutants in isolated LDs
To confirm the IF results, we examined LDs isolated from
transfected FRT cells for the presence of wild-type Cav-KKSL
or selected KKSL-tagged mutants (Fig. 8). Aliquots of whole
cell homogenate (Fig. 8, WC) and isolated LDs (Fig. 8, LD)
from transfected FRT cells were probed for calnexin (to mon-
itor ER contamination of the LD fraction), ADRP (to moni-
tor LD yield), and various caveolin mutants (to monitor ex-
pression and LD targeting). In agreement with the IF results,
wild-type Cav-KKSL and 97/SASA-KKSL were present in
LDs, whereas Ins-7L(1 2)-KKSL and Ins-7L(1 2)  112-
125-KKSL were largely excluded from LDs (Fig. 8).
Discussion
We provided additional support for our model of LD target-
ing of caveolin-1 (Ostermeyer et al., 2001). In this model,
we suggested that when caveolins accumulate in the ER,
they reach the surface of nascent LDs by diffusion in the ER
membrane. Consistent with this idea, BFA-induced LD tar-
geting of caveolin-1 did not require microtubules or mi-
crofilaments. The model predicts that caveolin-1 must be in
the ER at the time of BFA treatment to enter LDs. As pre-
dicted, treatment of cells with cycloheximide to prevent new
caveolin-1 synthesis and ER insertion during BFA treatment
prevented BFA-induced LD accumulation.
Although this model explains how caveolins reach the LD
surface, it does not explain why they become so concentrated
there. Nonpalmitoylated H-Ras, whose ER localization and
topology suggest it should be able to reach LDs as well as ca-
veolins, never accumulated there. Thus, our second goal was
to learn why caveolins have such a high affinity for LDs.
Importance of the hydrophobic domain in LD targeting
The hydrophobic domain, though no specific sequences
therein, was required for LD targeting of caveolin-1. In
contrast, the hydrophobic domain was not essential for
membrane association of caveolin-1. Thus, membrane as-
sociation was not sufficient for LD targeting. Several
pieces of evidence suggested that the unusual topology of
caveolin-1, with two cytoplasmic domains flanking a cen-
tral hydrophobic domain, is a crucial determinant of LD
targeting of integral proteins. First, bona fide integral LD
proteins, oleosins and caleosins, have the same topology
(Huang, 1992; Chen et al., 1999). Second, caveolin-1
mutants that lacked the entire hydrophobic domain or
that ended after the first half of the domain were not tar-
geted to LDs. Similarly, a caveolin-2 mutant that lacked
the hydrophobic domain was not detected in LDs (Fu-
jimoto et al., 2001). Nevertheless, mutational analysis
showed that no specific residues in the hydrophobic do-
main were essential for LD targeting. This finding showed
that a Pro knot motif, shown to be important in LD tar-
geting of oleosins (Abell et al., 1997) and HCV core
(Hope et al., 2002), is not universally required for LD tar-
geting of integral proteins.
Figure 8. KKSL-tagged caveolin-1 mutants in isolated LDs. LDs 
were isolated from oleic acid–treated FRT cells expressing Cav-KKSL, 
97/SASA-KKSL, Ins-7L(1 2)-KKSL, or Ins-7L(1 2)  112-125-KKSL 
as indicated. Proteins in the LDs (LD) or in a reserved 5% of the whole 
cell homogenate (WC) were analyzed by SDS-PAGE and Western 
blotting and detected by ECL. Blots were cut in three parts. Top, 
probed with anticalnexin and HRP-donkey anti–rabbit IgG. Middle, 
anti-ADRP and HRP-GAM. Bottom, anticaveolin and HRP-donkey 
anti–rabbit IgG. Schematic depictions of proteins are as in Fig. 7.76 The Journal of Cell Biology | Volume 164, Number 1, 2004
Leu insertions in the hydrophobic domain can block 
LD targeting of caveolin-1
Although no residues in the hydrophobic domain of caveo-
lin-1 were absolutely required, certain insertion mutations in
this domain greatly reduced LD targeting. Inserting two
7-Leu segments into the hydrophobic domain, one near each
end, blocked LD targeting. LD targeting was blocked even
when the central 14 residues of the hydrophobic domain
were also deleted to restore the normal length of the hydro-
phobic domain. Simply deleting the 14 central hydrophobic
residues from the wild-type protein, to shorten the domain,
did not block LD targeting. LD targeting of mutants con-
taining only one 7-Leu insertion was not affected. Similarly,
inserting two 7-Leu segments, both near the NH2-terminal
end of the hydrophobic domain, did not block LD target-
ing. Thus, the position of the inserted Leu residues in the
hydrophobic domain, rather than their number or total hy-
drophobic domain length, could affect LD targeting.
Leu insertions might affect hydrophobic helix packing
The fact that we do not know the structure of the hydropho-
bic domain of caveolin-1 limits interpretation of our results.
However, an attractive model is that this domain forms two  
helices, which are separated by a tight turn. The need to sat-
isfy backbone hydrogen bonds places severe constraints on the
possible conformations of lipid-embedded protein domains.
With the exception of   barrel structures in certain bacterial
proteins, all known transmembrane peptides are  -helical
(Monné et al., 1999). It is important to note, though, that the
hydrophobic domain of oleosins has been suggested to form
an extended   strand that aligns parallel to strands in adjacent
molecules (Li et al., 2002), although others have suggested
that the domain is helical (Lacey et al., 1998). Nevertheless, a
model protein with a hydrophobic domain as short as 31 resi-
dues was shown to be able to form a helix-turn-helix motif,
without an absolute requirement for Pro at the turn (Monné
et al., 1999). Thus, we will next consider a model for how Leu
insertions might affect LD targeting of caveolin-1 if the hy-
drophobic domain were to form a helix-turn-helix motif.
As schematized in Fig. 9 (A and B), we suggest that proper
packing of the two putative hydrophobic helices is impor-
tant in LD targeting of caveolin-1. Seven Leu would form
two turns of an   helix. We speculate that the bulky Leu
side chains interfere with correct packing of the helices with
each other, or with other membrane proteins. One 7-Leu in-
sertion alone or insertion of 14 Leu near one end of the hy-
drophobic domain might be tolerated. However, simulta-
neous insertion of seven Leu into both helices might disrupt
helix packing enough to block LD targeting, particularly if
the helices normally pack against each other. Consistent
with this possibility, as shown in Fig. 9 C, one face of a helix
formed by the first half of the hydrophobic domain would
consist entirely of Gly and Ala, whose small side chains are
highly favored on hydrophobic helix faces that pack closely
with other helices in membranes (Eilers et al., 2002).
The COOH-terminal domain of caveolin-1 may enhance
LD targeting, although the reduced expression of  C limits
the certainty of this conclusion. However, it is notable that
the hydrophobic domain of caveolin-2 alone, fused to
EGFP, did not localize to LDs (Fujimoto et al., 2001). This
is consistent with the idea that other sequences in caveo-
lin-1, in addition to the hydrophobic domain, are required
for LD targeting. Such sequences (possibly including the
COOH-terminal domain) may facilitate LD targeting by
stabilizing correct packing of the hydrophobic domain.
Role of the Pro knot in LD targeting
The precise role of the Pro knot motif in LD targeting of ole-
osins (and probably caleosins) and HCV core (Hope et al.,
2002) is not known. In oleosins, this motif lies in the center of
the 70-residue hydrophobic domain, where it has been pro-
posed to induce formation of a 180  turn (Tzen et al., 1992).
It might be imagined that the two resulting 35-residue hydro-
phobic helices (or, possibly,  -sheet structures; Huang, 1992)
are too long to fit well in the ER bilayer. Thus, one model is
that the Pro knot forces formation of helices that are too long
for the bilayer but can be accommodated in LDs.
This model is less appealing in explaining the role of the Pro
knot in LD targeting of other proteins. First, their hydrophobic
domains are much shorter than those of oleosins and could eas-
ily be accommodated in bilayers, which can accommodate heli-
cal hairpins (Monné et al., 1999). Furthermore, although the
central domains of HCV and GBV-B core proteins are more
hydrophobic than adjacent domains, they contain several charged
residues and could form amphipathic helices, as illustrated for
the 24 residues downstream of the Pro knot of HCV core (Fig.
9 D). One face of this putative helix contains almost exclusively
charged residues (Fig. 9 D, squares), and is unlikely to be com-
pletely embedded in a bilayer or an LD. Instead, a helix formed
Figure 9. Model depicting role of hydrophobic helix packing in 
LD targeting of caveolin-1. We speculate here that the hydrophobic 
domain of caveolin-1 forms two   helices separated by a tight turn. 
(A) We propose that correct packing of the putative hydrophobic heli-
ces is required for LD targeting of wild-type caveolin-1. (B) Insertion 
of bulky Leu residues in both helices could inhibit LD targeting 
sterically by preventing proper helix packing. (C) Helical wheel 
depiction of the first half of the hydrophobic domain of caveolin-1 
(R101 at the membrane interface [underlined] through Y119 [*]). 
Circles, residues on a Gly   Ala–rich helix face. (D) L144 (underlined) 
through A165 of the core coding region of HCV strain Glasgow 
(genotype 1a; Hope and McLauchlan, 2000), just downstream of 
the P138   P143 motif, modeled as an   helix. Circles, residues on 
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by these residues would probably lie parallel to the surface, like
other amphipathic helices (Johnson and Cornell, 1999). Simi-
larly, the Pro knot in caleosins is at the end of the hydrophobic
domain, adjacent to a highly charged sequence that could form
an amphipathic helix (Naested et al., 2000). Thus, the Pro mo-
tif probably does not generally act in LD targeting by forcing
formation of excessively long hydrophobic helices.
Is proper hydrophobic domain packing generally 
required for LD targeting?
We have suggested that proper hydrophobic helix packing may
be important in LD targeting of caveolins. This may be true of
other LD proteins as well. Lipid-embedded helices generally
pack more tightly than helices in soluble proteins (Eilers et al.,
2000), and we speculate that tight packing might be especially
important in LD proteins. A helix formed by the 24 residues
downstream of the Pro knot in HCV core would have a Gly  
Ala–rich face (Fig. 9 D, circles). Also, the NH2-terminal half of
the hydrophobic domain of oleosins is unusually rich in Gly,
Ala, and Ser (Tzen et al., 1992), which are favored at contact
sites between membrane-embedded helices (Eilers et al.,
2002). The Pro knot may act in LD targeting by affecting hy-
drophobic helix packing. Caveolins may achieve the same end
(correct packing) by a different mechanism. It is even possible
that the puzzling results of studies on LD targeting of ADRP
and perilipins (Garcia et al., 2003; Targett-Adams et al., 2003)
reflect a requirement for apparently redundant LD targeting
motifs to pack together correctly for optimal LD targeting.
Despite the fact that LDs are present in most eukaryotic
cells, surprisingly little is known about their synthesis or me-
tabolism, or about how proteins are targeted to their surface.
Our findings suggest that correct hydrophobic domain pack-
ing may be crucial for LD targeting of caveolins and possibly
of other proteins as well. Further work will be required to
learn how this targeting works and how LD proteins function.
Materials and methods
Cells and reagents
FRT and COS-1 cells have been described previously (Ostermeyer et al.,
2001). Primary antibodies used were as follows: rabbit anti–caveolin-1 and
mouse anti-GM130 (Transduction Laboratories); mouse antiadipophilin/
ADRP (Research Diagnostics); rabbit anti-PLAP (DakoCytomation); mouse
anti-myc (Invitrogen); rabbit anticalnexin (Manganas et al., 2001; gift of J.
Trimmer, University of California, Davis, Davis, CA). Secondary antibodies
used were as follows: dichlorotriazinylaminofluorescein (DTAF)-goat anti–
mouse Ig(G   M) (GAM), FITC-goat anti–rabbit IgG (GAR), Texas red–GAR
and GAM, HRP-GAM and HRP-donkey anti–rabbit IgG (Jackson Immu-
noResearch Laboratories), and Alexa Fluor 350-GAR (Molecular Probes).
Lipofectamine 2000 was obtained from GIBCO BRL, and other reagents
were obtained from Sigma-Aldrich.
Plasmids
Plasmids encoding GFP–H-Ras and the nonpalmitoylated GFP–H-
RasC181S,C184S (Choy et al., 1999) were gifts of M. Philips (New York
University, New York, NY). A plasmid encoding the hybrid protein PLAP-
HA, containing the extracellular domain of PLAP and the transmembrane
and cytoplasmic domains of influenza hemagglutinin, has been described
previously (Arreaza and Brown, 1995). Plasmids encoding NH2-terminal
HA-tagged and COOH-terminal myc-tagged canine caveolin-1 (  iso-
form), a nonpalmitoylated mutant of this protein (Cys ), and Cav- N2 (re-
ferred to here as  N2) have been described previously (Dietzen et al.,
1995; Ostermeyer et al., 2001). Additional canine caveolin-1 mutants
were generated using the QuikChange site-directed mutagenesis kit (Strat-
agene) or by PCR and verified by sequencing. Non–self-explanatory mu-
tants are as follows, using the residue numbers in canine caveolin-1  : Ins-
7L(1   2), insertion of seven Leu after A105 and seven Leu after V130; Ins-
7L1, insertion of seven Leu after A105; Ins-7L2, insertion of seven Leu after
V130; Ins-14L, insertion of seven Leu after A105, and seven Leu after I109.
The names 102A5, 107A5, 113A5, 118A5, 123A6, and 130A5 refer to
substitution of Ala for the indicated number of residues (5–6), starting with
the indicated residue. 97/SASA; Y97, W98, F99, Y100 changed to SASA,
respectively.  N1, lacks G3-E48;  N2, lacks T46-T95;  C, lacks S136-
T178; and  59, lacks A120-T178. All mutants contained an NH2-terminal
HA tag. All except  59 contained a COOH-terminal myc tag.
Procedures
Cells were transiently transfected using Lipofectamine 2000 and observed
1 or 2 d after transfection. IF using an epifluorescence microscope (model
Axioskop 2; Carl Zeiss MicroImaging, Inc.) was as described previously
(Ostermeyer et al., 2001), except that PFA fixation and permeabilization
were performed at 25–27 C, and methanol fixation (10 min, 0 C) was used
for detection of the LD marker protein ADRP (Brasaemle et al., 1997b). Al-
though this distorted LD shape (DiDonato and Brasaemle, 2003), colocal-
ization of ADRP and caveolin on LDs could be detected. All images were
obtained with a 100  objective (NA   1.3). Images were captured with a
SPOT cooled CCD 24-bit color digital camera (Diagnostic Instruments,
Inc.) and processed using Adobe Photoshop. Where indicated, cells were
incubated with media containing 10  g/ml BFA, 50  g/ml cycloheximide,
10  g/ml cytochalasin B, and/or 10  M nocodazole for 5 h before fixation.
In IF experiments, wild-type and mutant caveolin-1 were detected with
anti–caveolin-1 antibodies and DTAF-GAR, except as noted next. When
coexpressed with PLAP-HA, caveolin-1 was detected with anti-myc anti-
bodies. For colocalization with Nile red, caveolin-1 was detected with
blue Alexa Fluor 350 GAR secondary antibodies, though resolution was
lower than with DTAF-GAR, because the fluorescence absorbance profile
of Nile red overlaps with both DTAF (green) and with Texas red.
LD isolation from oleic acid–treated FRT cells and recovery of LD pro-
teins by acetone precipitation were performed as described previously (Gar-
cia et al., 2003) with the following minor modifications. Oleic acid–defatted
BSA complexes were added to cells in one confluent 10-cm dish 5 h after
transfection. The next day, cells were scraped from the dish, washed in PBS,
washed in homogenization buffer (10 mM Hepes, pH 7.4, and 5 mM EDTA),
resuspended in 200  l homogenization buffer with protease inhibitors (1  g/
ml pepstatin, 0.2 mM PMSF, and 1  g/ml leupeptin), and homogenized by
35 passages through a 25-gauge needle. An aliquot of homogenate was re-
served. The remainder was adjusted to 1 ml with homogenization buffer
with protease inhibitors and subjected to centrifugation at 100,000 g for 30
min in an ultracentrifuge (model Optima TL; Beckman Coulter). The top 200
 l, containing the LDs, was harvested, and LD proteins were collected by
acetone precipitation. SDS-PAGE, transfer to nylon membranes, and West-
ern blotting were performed as described previously (Schroeder et al., 1998).
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